COMMUNIQUÉS West-GlobeNewswire

-
Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes
20/12/2018 -
Form 8 (DD) - Gail Fosler
20/12/2018 -
Supernus Announces Positive Results from Phase III Study For SPN-812 in Adolescents with ADHD
20/12/2018 -
Bellicum Pharmaceuticals Announces Appointment of Judith Klimovsky, M.D., to Board of Directors
20/12/2018 -
Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy
20/12/2018 -
Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
20/12/2018 -
FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease
20/12/2018 -
Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults
20/12/2018 -
miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma and Cutaneous T-Cell Lymphoma at the 11th Annual T-Cell Lymphoma Forum
20/12/2018 -
Form 8 (DD) - Steven Gillis
20/12/2018 -
Form 8 (DD) - Sara Mathew
20/12/2018 -
New Data on AlloSure Confirms Its Clinical Utility in Repeat Kidney Transplant Recipients
20/12/2018 -
iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures
20/12/2018 -
Form 8 (DD) - Albert Stroucken
20/12/2018 -
Form 8 (DD) - Susan Kilsby
20/12/2018 -
Form 8 (DD) - David Ginsburg
20/12/2018 -
Avivagen Announces Proposed Extension of Warrants
20/12/2018 -
Eton Pharmaceuticals Reports Third Quarter Results and Business Update
20/12/2018 -
ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAM® PAS Submissions
20/12/2018
Pages